Selected research
Industry Research
Cinnarizine Industry Research Report 2026
Market perspective
The global Cinnarizine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cinnarizine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cinnarizine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cinnarizine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cinnarizine include Teva, Johnson And Johnson, Novartis, Mylan, Zambon, Sopharma, Nidda Healthcare, March Pharma and Leti Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cinnarizine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cinnarizine Market by Company
Teva
Johnson And Johnson
Novartis
Mylan
Zambon
Sopharma
Nidda Healthcare
March Pharma
Leti Pharma
Inga Laboratories
Hasco-Lek
Goodwill Pharma
Gedeon Richter
Eurogenerics
Aurobindo Pharma
Apotex
Allena Pharmaceuticals
Cinnarizine Segment by Type
On-line
Drug Store
Hospital
Cinnarizine Segment by Application
Histamine H₁-Receptor Antagonist
Antiemetic Agent
Antivertigo Agent
Cinnarizine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cinnarizine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cinnarizine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cinnarizine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cinnarizine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cinnarizine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cinnarizine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- On-line
- Drug Store
- Hospital
Applications
- Histamine H₁-Receptor Antagonist
- Antiemetic Agent
- Antivertigo Agent
Companies covered
- Teva
- Johnson And Johnson
- Novartis
- Mylan
- Zambon
- Sopharma
- Nidda Healthcare
- March Pharma
- Leti Pharma
- Inga Laboratories
- Hasco-Lek
- Goodwill Pharma
- Gedeon Richter
- Eurogenerics
- Aurobindo Pharma
- Apotex
- Allena Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cinnarizine Market Size (2021-2032)
- 2.2.2 Global Cinnarizine Sales (2021-2032)
- 2.2.3 Global Cinnarizine Market Average Price (2021-2032)
- 2.3 Cinnarizine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 On-line
- 2.3.3 Drug Store
- 2.3.4 Hospital
- 2.4 Cinnarizine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Histamine H₁-Receptor Antagonist
- 2.4.3 Antiemetic Agent
- 2.4.4 Antivertigo Agent
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cinnarizine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cinnarizine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Cinnarizine Revenue of Manufacturers (2021-2026)
- 3.4 Global Cinnarizine Average Price by Manufacturers (2021-2026)
- 3.5 Global Cinnarizine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cinnarizine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cinnarizine, Product Type & Application
- 3.8 Global Manufacturers of Cinnarizine, Established Date
- 3.9 Global Cinnarizine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Cinnarizine Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Johnson And Johnson
- 4.2.1 Johnson And Johnson Company Information
- 4.2.2 Johnson And Johnson Business Overview
- 4.2.3 Johnson And Johnson Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Johnson And Johnson Cinnarizine Product Portfolio
- 4.2.5 Johnson And Johnson Recent Developments
- 4.3 Novartis
- 4.3.1 Novartis Company Information
- 4.3.2 Novartis Business Overview
- 4.3.3 Novartis Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Novartis Cinnarizine Product Portfolio
- 4.3.5 Novartis Recent Developments
- 4.4 Mylan
- 4.4.1 Mylan Company Information
- 4.4.2 Mylan Business Overview
- 4.4.3 Mylan Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mylan Cinnarizine Product Portfolio
- 4.4.5 Mylan Recent Developments
- 4.5 Zambon
- 4.5.1 Zambon Company Information
- 4.5.2 Zambon Business Overview
- 4.5.3 Zambon Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Zambon Cinnarizine Product Portfolio
- 4.5.5 Zambon Recent Developments
- 4.6 Sopharma
- 4.6.1 Sopharma Company Information
- 4.6.2 Sopharma Business Overview
- 4.6.3 Sopharma Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sopharma Cinnarizine Product Portfolio
- 4.6.5 Sopharma Recent Developments
- 4.7 Nidda Healthcare
- 4.7.1 Nidda Healthcare Company Information
- 4.7.2 Nidda Healthcare Business Overview
- 4.7.3 Nidda Healthcare Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Nidda Healthcare Cinnarizine Product Portfolio
- 4.7.5 Nidda Healthcare Recent Developments
- 4.8 March Pharma
- 4.8.1 March Pharma Company Information
- 4.8.2 March Pharma Business Overview
- 4.8.3 March Pharma Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 March Pharma Cinnarizine Product Portfolio
- 4.8.5 March Pharma Recent Developments
- 4.9 Leti Pharma
- 4.9.1 Leti Pharma Company Information
- 4.9.2 Leti Pharma Business Overview
- 4.9.3 Leti Pharma Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Leti Pharma Cinnarizine Product Portfolio
- 4.9.5 Leti Pharma Recent Developments
- 4.10 Inga Laboratories
- 4.10.1 Inga Laboratories Company Information
- 4.10.2 Inga Laboratories Business Overview
- 4.10.3 Inga Laboratories Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Inga Laboratories Cinnarizine Product Portfolio
- 4.10.5 Inga Laboratories Recent Developments
- 4.11 Hasco-Lek
- 4.11.1 Hasco-Lek Company Information
- 4.11.2 Hasco-Lek Business Overview
- 4.11.3 Hasco-Lek Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Hasco-Lek Cinnarizine Product Portfolio
- 4.11.5 Hasco-Lek Recent Developments
- 4.12 Goodwill Pharma
- 4.12.1 Goodwill Pharma Company Information
- 4.12.2 Goodwill Pharma Business Overview
- 4.12.3 Goodwill Pharma Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Goodwill Pharma Cinnarizine Product Portfolio
- 4.12.5 Goodwill Pharma Recent Developments
- 4.13 Gedeon Richter
- 4.13.1 Gedeon Richter Company Information
- 4.13.2 Gedeon Richter Business Overview
- 4.13.3 Gedeon Richter Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Gedeon Richter Cinnarizine Product Portfolio
- 4.13.5 Gedeon Richter Recent Developments
- 4.14 Eurogenerics
- 4.14.1 Eurogenerics Company Information
- 4.14.2 Eurogenerics Business Overview
- 4.14.3 Eurogenerics Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Eurogenerics Cinnarizine Product Portfolio
- 4.14.5 Eurogenerics Recent Developments
- 4.15 Aurobindo Pharma
- 4.15.1 Aurobindo Pharma Company Information
- 4.15.2 Aurobindo Pharma Business Overview
- 4.15.3 Aurobindo Pharma Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Aurobindo Pharma Cinnarizine Product Portfolio
- 4.15.5 Aurobindo Pharma Recent Developments
- 4.16 Apotex
- 4.16.1 Apotex Company Information
- 4.16.2 Apotex Business Overview
- 4.16.3 Apotex Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Apotex Cinnarizine Product Portfolio
- 4.16.5 Apotex Recent Developments
- 4.17 Allena Pharmaceuticals
- 4.17.1 Allena Pharmaceuticals Company Information
- 4.17.2 Allena Pharmaceuticals Business Overview
- 4.17.3 Allena Pharmaceuticals Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Allena Pharmaceuticals Cinnarizine Product Portfolio
- 4.17.5 Allena Pharmaceuticals Recent Developments
5 Global Cinnarizine Market Scenario by Region
- 5.1 Global Cinnarizine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cinnarizine Sales by Region: 2021-2032
- 5.2.1 Global Cinnarizine Sales by Region: 2021-2026
- 5.2.2 Global Cinnarizine Sales by Region: 2027-2032
- 5.3 Global Cinnarizine Revenue by Region: 2021-2032
- 5.3.1 Global Cinnarizine Revenue by Region: 2021-2026
- 5.3.2 Global Cinnarizine Revenue by Region: 2027-2032
- 5.4 North America Cinnarizine Market Facts & Figures by Country
- 5.4.1 North America Cinnarizine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cinnarizine Sales by Country (2021-2032)
- 5.4.3 North America Cinnarizine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Cinnarizine Market Facts & Figures by Country
- 5.5.1 Europe Cinnarizine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cinnarizine Sales by Country (2021-2032)
- 5.5.3 Europe Cinnarizine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Cinnarizine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cinnarizine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cinnarizine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cinnarizine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cinnarizine Market Facts & Figures by Country
- 5.7.1 South America Cinnarizine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cinnarizine Sales by Country (2021-2032)
- 5.7.3 South America Cinnarizine Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Cinnarizine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cinnarizine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cinnarizine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cinnarizine Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Cinnarizine Sales by Type (2021-2032)
- 6.1.1 Global Cinnarizine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Cinnarizine Sales Market Share by Type (2021-2032)
- 6.2 Global Cinnarizine Revenue by Type (2021-2032)
- 6.2.1 Global Cinnarizine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cinnarizine Revenue Market Share by Type (2021-2032)
- 6.3 Global Cinnarizine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cinnarizine Sales by Application (2021-2032)
- 7.1.1 Global Cinnarizine Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Cinnarizine Sales Market Share by Application (2021-2032)
- 7.2 Global Cinnarizine Revenue by Application (2021-2032)
- 7.2.1 Global Cinnarizine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cinnarizine Revenue Market Share by Application (2021-2032)
- 7.3 Global Cinnarizine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cinnarizine Value Chain Analysis
- 8.1.1 Cinnarizine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cinnarizine Production Mode & Process
- 8.2 Cinnarizine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cinnarizine Distributors
- 8.2.3 Cinnarizine Customers
9 Global Cinnarizine Analyzing Market Dynamics
- 9.1 Cinnarizine Industry Trends
- 9.2 Cinnarizine Industry Drivers
- 9.3 Cinnarizine Industry Opportunities and Challenges
- 9.4 Cinnarizine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst